Abstract
The transport of methotrexate (MTX) into Walker 256 carcinoma (W256) and hepatoma 5123 (H5123) transplanted in rats was investigated after a pulse injection and continuous infusion of the drug. A mathematical model was developed which adequately described the distribution and transport of MTX in both solid tumors. In H5123 the uptake was limited by the amount of drug carried by plasma (flow-limited transport), but in W256 MTX uptake was limited by the rate at which the drug crossed the tissue barriers (tissue-limited transport). Relative uptake by the solid tumors was almost eightfold more efficient with low than with high doses. MTX concentration in tumor interstitial fluid equilibrated with that of plasma in about 50 hr using a micropore chamber with a diffusion coefficient of 0.5 Μm/min as sampling device. MTX concentration was higher in resistant than in responsive tumors.
Similar content being viewed by others
References
R. L. Dedrick, D. S. Zaharko, and R. J. Lutz. Transport and binding of methotrexate.in vivo. J. Pharm. Sci. 62:882–890 (1973).
R. K. Jain. Dynamics of drug distribution in solid tumors. Ph.D. thesis, Department of Chemical Engineering, University of Delaware, Newark, Del., 1976.
I. D. Goldman. Uptake of drugs and resistance. InDrug Resistance and Selectivity: Biochemical and Cellular Basis, Academic Press, New York, 1973.
R. K. Jain and J. Wei. Dynamics of drug transport in solid tumors: Distributed parameter model.J. Bioeng. 1:313–330 (1977).
C. A. Nichol, F. Rosen, and L. C. Mishra. Slow uptake of amethopterin by Walker carcinoma 256.Proc. 9th Int. Cancer Conf., Tokyo, Japan, 1966, p. 356.
F. Rosen, H. Sotobayashi, and C. A. Nichol. Different effects of folic acid deficiency and treatment with amethopterin on the growth of several rat tumors.Proc. Am. Assoc. Cancer Res. 5:54 (1964).
W. C. Werkheiser. The biochemical, cellular, and pharmacological action and effects of the folic acid antagonists.Cancer Res. 23:1277–1285 (1963).
R. J. Lutz, R. L. Dedrick, J. A. Straw, M. M. Hart, P. Khubes, and D. S. Zaharko. The kinetics of methotrexate distribution in spontaneous canine lymphocarcoma.J. Pharmacokin. Biopharm. 3:77–97 (1975).
R. L. Dedrick, R. J. Lutz, K. H. Yang, W. P. Fung, and D. S. Zaharko. Pharmacokinetic model for the transport of methotrexate into Lewis lung tumor in mice. Reprint of the paper presented at the 70th Annual AIChE Meeting, New York, 1977.
J. M. Weissbrod, R. K. Jain, and F. M. Sirotnak. Pharmacokinetics of methotrexate in leukemia cells: Effect of dose and mode of injection.J. Biopharmacokin. Biopharm. 6:487–511 (1978).
P. M. Gullino. The internal milieu of tumors.Prog. Exp. Tumor Res. 8:1–25 (1966).
H. L. Steward, K. C. Snell, L. J. Dunham, and S. M. Schuylen. Transplantable and transmissible tumors of animals. InAtlas of Tumor Pathology, Section XII, Fascicle 40, Armed Forces Institute of Pathology, Washington, D.C., 1959, p. 261.
H. P. Morris, H. Sidransky, B. P. Wagner, and H. M. Dyer. Some characteristics of transplantable rat hepatoma No. 5123 induced by ingestion ofN-(2-fluorenyl)phthalamic acid.Cancer Res. 20:1252–1254 (1960).
P. M. Gullino. Techniques for the study of tumor pathophysiology. In H. Busch (ed.),Methods in Cancer Research, Vol. 5, Academic Press, New York, 1970, pp. 45–92.
V. T. Oliverio. Chromatographic separation and purification of folic acid analogs.Anal. Chem. 33:263–265 (1961).
F. H. Grantham, D. M. Hill, J. Rowland, and P. M. Gullino. Cage for continuous intravascular infusion of isotopes and drugs in small animals.J. Natl. Cancer Inst. 55:203–205 (1975).
D. S. Zaharko, H. Bruckner, and V. T. Oliverio. Antibiotics alter methotrexate metabolism and excretion.Science 166:887–888 (1969).
D. T. Mahin and R. T. Lofberg. A simplified method of sample preparation for determination of tritium, carbon-14, or tissue sulfur-35, in blood or tissue by liquid scintillation counting.Anal. Biochem. 16:500–509 (1966).
P. W. Montigney. Pharmacokinetics of methotrexate in subcutaneous rat tumors. B.Ch.E. thesis, Department of Chemical Engineering, University of Delaware, Newark, Del., 1974.
G. A. Fischer. Increased levels of folic acid reductase as a mechanism of resistance to amethopterin in leukemia cells.Biochem. Pharmacol. 7:75–77 (1961).
M. T. Hakala and R. P. Raumio. Comparison of folate reductase of sarcoma-180 cells, sensitive and resistant to amethopterin.Mol. Pharmacol. 3:279–283 (1967).
R. L. Dedrick, D. S. Zaharko, R. A. Bender, W. A. Bleyer, and R. J. Lutz. Pharmacokinetic considerations on resistance to anticancer drugs.Cancer Chemother. Rep. 59:795–805 (1975).
Author information
Authors and Affiliations
Additional information
This work was supported by the American Cancer Society Grant No. DT-8.
Rights and permissions
About this article
Cite this article
Jain, R.K., Wei, J. & Gullino, P.M. Pharmacokinetics of methotrexate in solid tumors. Journal of Pharmacokinetics and Biopharmaceutics 7, 181–194 (1979). https://doi.org/10.1007/BF01059737
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01059737